Cargando…

Functional Significance of Cardiac Rehabilitation-Regulated Expression of Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure with a Moderately Reduced Ejection Fraction

BACKGROUND: Hypertension is a vital risk factor for heart failure, while cardiac rehabilitation can effectively improve cardiac function of heart failure patients. This study aimed to determine the impact of cardiac rehabilitation on microRNA-423-5p in hypertensive patients with heart failure with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ying, Zhang, Yun, Nong, Wenzheng, Lan, Biyang, Zhang, Dingmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Society of Cardiology 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366441/ https://www.ncbi.nlm.nih.gov/pubmed/35552172 http://dx.doi.org/10.5152/AnatolJCardiol.2021.276

Ejemplares similares

Reply to Letter to the Editor: “Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure: Correspondence”
por: Huang, Ying, et al.
Publicado: (2022)

Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Strain-Dependent Modifier Genes Determine Survival in Zfp423 Mice
por: Alcaraz, Wendy A., et al.
Publicado: (2020)

Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients
por: Liao, Li Ping, et al.
Publicado: (2022)

Circulating microRNA-423 attenuates the phosphorylation of calcium handling proteins in atrial fibrillation
por: Park, Hyewon, et al.
Publicado: (2022)

Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients
por: Kwon, Hee-Jin, et al.
Publicado: (2019)

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
por: Chen, Yei-Tsung, et al.
Publicado: (2019)

Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction
por: Barman, Hasan Ali, et al.
Publicado: (2019)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
por: Edmonston, Daniel, et al.
Publicado: (2023)

Circulating levels of microRNA 423‐5p are associated with 90 day mortality in cardiogenic shock
por: Jäntti, Toni, et al.
Publicado: (2018)

The prognostic value of altitude in patients with heart failure with reduced ejection fraction
por: Kaya, Ahmet, et al.
Publicado: (2019)

Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction
por: Lee, Chan Joo, et al.
Publicado: (2020)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

Functional mechanism and clinical implications of MicroRNA‐423 in human cancers
por: Ke, RuiSheng, et al.
Publicado: (2020)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

Vaccine‐preventable disease hospitalized patients with heart failure with reduced ejection fraction
por: Del Cid Fratti, Juan, et al.
Publicado: (2022)

Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

MiR-423-5p as Optimal Endogenous Control for Quantification of Circulating MicroRNAs in Patients With CKD
por: Wong, Limy, et al.
Publicado: (2023)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction
por: Örsçelik, Özcan, et al.
Publicado: (2023)

Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction
por: Zhang, Yi, et al.
Publicado: (2020)

Impact of left ventricular ejection fraction on the results of cardiac rehabilitation
por: Peters, R. J. G.
Publicado: (2019)

MicroRNA-126 Level Increases During Exercise Rehabilitation of Heart Failure with a Preserved Ejection Fraction
por: Jin, Dong, et al.
Publicado: (2021)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity()()
por: Alatas, Emine Tugba, et al.
Publicado: (2020)

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
por: Connelly, Kim A., et al.
Publicado: (2020)

Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes
por: Li, Junfeng, et al.
Publicado: (2016)

Left ventricular twist was decreased in isolated left bundle branch block with preserved ejection fraction
por: Yılmaz, Sabiye, et al.
Publicado: (2017)

Effect of obstructive sleep apnea on right ventricular ejection fraction in patients with hypertrophic obstructive cardiomyopathy
por: Wang, Shengwei, et al.
Publicado: (2020)

Relationship between myocardial energy expenditure and postoperative ejection fraction in patients with severe mitral regurgitation
por: Ağuş, Hicaz Zencirkıran, et al.
Publicado: (2020)

Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Kitai, Takeshi, et al.
Publicado: (2020)

Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
por: Frisk, Michael, et al.
Publicado: (2021)

Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults
por: Zhao, Li, et al.
Publicado: (2022)

Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction
por: Scandalis, Lina, et al.
Publicado: (2023)

Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction
por: Zhang, Nannan, et al.
Publicado: (2019)

Prognostic Implications of Changes in Left Ventricular Ejection Fraction and Pulmonary Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
por: Kim, Hyun-Jin
Publicado: (2019)

Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study
por: Özlek, Bülent, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ned893m5aiaea79qeat1jrp2e